Geopolitical Tensions05/05/2026Antibiotics: Europe at risk with fragile supplies and heavy dependence on Asia
Digital health15/04/2026Ia already in 78% of medtech companies, but innovation does not reach patients
Luiss Business School24/03/2026Pharmaceuticals: US bigwigs give 9 billion boost, more incentives for research
The unknowns24/03/2026Cyclone Trump and the Hormuz crisis, all the risks impacting the pharmaceutical industry
The numbers24/03/2026Made in Italy pharmaceuticals win over tariffs: Tuscany, Abruzzo and Lazio among the export queens
Investing for Life Msd Italia04/03/2026Waiting lists and innovation: Italians rate the NHS and indicate priorities
Pharmaceutical Industry Association27/02/2026The drug industry is already in the age of artificial intelligence
This is the general manager12/02/2026 Roche: 'In Italia payback and bureaucracy hold back drug investments'
Cures and the market11/02/2026Neonatal screening, not only prevention Doc: rising market registers entry of Helyx Industries
Assosalute09/02/2026Over-the-counter medicines: e-commerce grows but does not break through, Italians go to the pharmacy
The legal battle07/01/2026Bayer reopens patent war on Covid vaccines: lawsuits against big boys over mrna technology start
The Agreement12/12/2025Drugs: EU reform close to launch, for companies 'an own goal that will favour the US and China'
Assobiotec-Federchimica09/12/2025Biotech: 40% of turnover from healthcare, full steam ahead on precision medicine
Innovation31/10/2025Sanofi: for every euro invested in research, three euros are generated for the community
Observatory 202507/10/2025Egualia-Nomisma: time is up, without action equivalent medicines will disappear
Roche: 'In Italia payback and bureaucracy hold back drug investments'